Francesca Romana Mauro

Pubblicazioni

Titolo	Pubblicato in	Anno
Balancing efficacy and toxicity of targeted agents currently used for the treatment of patients with chronic lymphocytic leukemia	EXPERT REVIEW OF HEMATOLOGY	2018
Unravelling the suboptimal response of TP53-mutated chronic lymphocytic leukaemia to ibrutinib	BRITISH JOURNAL OF HAEMATOLOGY	2018
TP53 CLONAL AND SUBCLONAL ARCHITECTURE IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS UNDER IMMUNOCHEMOTHERAPY AND IBRUTINIB.	Haematologica, 2018; 103 (s3): s27	2018
Another treatment option for relapsed or refractory chronic lymphocytic leukaemia.	THE LANCET ONCOLOGY	2017
Clinical relevance of silent red blood cell autoantibodies.	HAEMATOLOGICA	2017
Chlorambucil plus rituximab as front-line therapy for elderly and/or unfit chronic lymphocytic leukemia patients: Correlation with biologically-based risk stratification	HAEMATOLOGICA	2017
Fludarabine, cyclophosphamide and lenalidomide in patients with relapsed/refractory chronic lymphocytic leukemia. A multicenter phase I–II GIMEMA trial	LEUKEMIA & LYMPHOMA	2017
Clinical relevance of hypogammaglobulinemia, clinical and biologic variables on the infection risk and outcome of patients with stage A chronic lymphocytic leukemia	LEUKEMIA RESEARCH	2017
Factors predicting survival in chronic lymphocytic leukemia patients developing Richter syndrome transformation into Hodgkin lymphoma	AMERICAN JOURNAL OF HEMATOLOGY	2017
Disappearance of Bone Marrow Fibrosis in a Patient with Chronic Myeloid Leukemia Treated with Dasatinib	CHEMOTHERAPY	2017
Prospective validation of predictive value of abdominal computed tomography scan on time to first treatment in Rai 0 chronic lymphocytic leukemia patients: results of the multicenter O-CLL1-GISL study.	EUROPEAN JOURNAL OF HAEMATOLOGY	2016
A case of concomitant chronic lymphocytic leukaemia and hairy cell leukaemia evaluated for IGHV-D-J rearrangements and BRAF-V600E mutation: lack of evidence for a common origin	BRITISH JOURNAL OF HAEMATOLOGY	2016
Inter- and intra-patient clonal and subclonal heterogeneity of chronic lymphocytic leukaemia: evidences from circulating and lymph nodal compartments	BRITISH JOURNAL OF HAEMATOLOGY	2016
A progression-risk score to predict treatment free survival for early stage chronic lymphocytic leukemia patients.	LEUKEMIA	2016
Clinical characteristics and outcome of patients with autoimmune hemolytic anemia (AIHA) uniformly defined as primary by a diagnostic work-up	AMERICAN JOURNAL OF HEMATOLOGY	2016
Combination of bendamustine and rituximab as front-line therapy for patients with chronic lymphocytic leukaemia: Multicenter, retrospective clinical practice experience with 279 cases outside of controlled clinical trials	EUROPEAN JOURNAL OF CANCER	2016
Autoimmune hemolytic anemia during bendamustine plus rituximab treatment in CLL patients: multicenter experience.	LEUKEMIA & LYMPHOMA	2016
Marked efficacy of Rituximab in multifocal motor neuropathy associated with chronic lymphocytic leukemia	OPEN JOURNAL OF CLINICAL & MEDICAL CASE REPORTS	2016
Marked efficacy of rituximab in multifocal motor neuropathy associated with chronic lymphocytic leukemia	OPEN JOURNAL OF CLINICAL & MEDICAL CASE REPORTS	2016
Validation of the CLL-IPI and comparison with the MDACC prognostic index in newly diagnosed patients	BLOOD	2016

Pubblicazioni

Progetti di Ricerca